Guardian Capital Advisors LP Bausch Health Companies Inc. Transaction History

Guardian Capital Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $449,651 - $1.5 Million	-63,690 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $584,064 - $751,441	27,040 Added 73.78%	63,690 $1.45 Million
Q4 2021 Feb 10, 2022	BUY	$23.0 - $29.01 $511,865 - $645,617	22,255 Added 154.6%	36,650 $992,000
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $28,044 - $33,667	-1,120 Reduced 7.22%	14,395 $400,000
Q2 2021 Aug 17, 2021	BUY	$27.43 - $32.7 $104,371 - $124,423	3,805 Added 32.49%	15,515 $462,000
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $117,321 - $188,746	-5,490 Reduced 31.92%	11,710 $348,000
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $123,934 - $170,966	8,095 Added 88.91%	17,200 $373,000
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $21,948 - $29,691	-1,475 Reduced 13.94%	9,105 $150,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $140,819 - $216,995	10,580 New	10,580 $175,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital Advisors LP with notifications on news.